This move is archived. Current quotes and coverage live on the stock page.
Follow CRON
Cronos Group Inc faced a notable decline in its stock price, reflecting investor concerns amidst a challenging market environment.
Yesterday, Cronos Group Inc (CRON.TO) experienced a significant drop of 4.49%, closing at CA$4.47. This decline adds to the growing apprehension among investors regarding the cannabis sector's performance.
Advertisement
Cronos Group Inc
CRON.TO
CRON.TO
Cronos Group Inc
WealthAwesomeMarket cap
$1.70B
P/E
17.1x
52W high
$4.99
52W low
$3.23
1W change
-2.77%
Beta
1.28
Analyst Price Targets
Based on analyst covering CRON · as of Sep 28, 2026
Wall Street analysts forecast CRON stock price to rise 14.6% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.24
+14.6% Upside
Previously C$4.92 on Sep 17, 2026
Current Price
C$4.57
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRON's historical volatility
30-Day Vol
38.3%
Annualized
90-Day Vol
39.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$5.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.89 | C$4.29 – C$5.58 |
| 60 trading days | C$5.19 | C$4.31 – C$6.26 |
| 90 trading days | C$5.51 | C$4.38 – C$6.93 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Cronos Group's recent product expansions may not be enough to offset market volatility and investor sentiment.
4.49% Decline
Cronos Group's stock fell 4.49% yesterday, reflecting investor uncertainty amidst ongoing market challenges.
Bull case
Cronos is actively innovating by expanding its product offerings with new flavors and formats in its Spinach® brand. This could attract consumer interest and boost future sales.
Bear case
The recent stock decline highlights broader challenges in the cannabis market, including regulatory hurdles and competition, which may limit Cronos' growth potential.
Market Overview
Advertisement
The cannabis sector has faced significant headwinds recently, with regulatory challenges and fluctuating consumer demand impacting stock performance. Cronos Group's decline is indicative of these broader market trends, raising concerns about the sustainability of its growth.
Product Innovations
Despite the stock's downturn, Cronos has been proactive in expanding its product lineup. The recent launch of new flavors in its Spinach® brand aims to capture consumer interest and maintain market relevance. However, it remains to be seen if these innovations will effectively change investor sentiment.
Looking Ahead
Investors should closely monitor Cronos Group's upcoming product launches and market strategies. While the recent decline is concerning, there may be opportunities for recovery if the company can successfully navigate the competitive landscape and address investor concerns.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
